NCT06994065View on ClinicalTrials.gov

Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients

NARecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Interventions
DRUG

Ferric Carboxymaltose (FCM)

This study will dose each patient according to their calculated iron deficit through Ganozi formula Iron deficit(mg) = bodyweight(kg) x (target Hb - actual Hb) (g/dl) x 2.4 + Iron storage depot(mg)

DRUG

Iron Sucrose injection

This study will dose each patient according to their calculated iron deficit through Ganozi formula Iron deficit(mg) = bodyweight(kg) x (target Hb - actual Hb) (g/dl) x 2.4 + Iron storage depot(mg)

Trial Locations (1)

Unknown

RECRUITING

Sindh Institute of Urology and Transplantaion, Karachi

All Listed Sponsors
lead

Sindh Institute of Urology and Transplantation

OTHER

NCT06994065 - Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients | Biotech Hunter | Biotech Hunter